The U.S. Food and Drug Administration (FDA) has approved wider usage of a test designed to quickly detect the influenza virus.
The procedure, developed by Alere, Inc., uses a molecular test to detect the genetic presence of the virus in a nasal swab. The test produces results in as fast as 15 minutes and has been cleared for use in all health care settings without a prescription.
The FDA previously approved the test as a prescription-only device last June, reports Fox News.
The FDA previously approved the test as a prescription-only device last June, reports Fox News.
No comments:
Post a Comment